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A B S T R A C T
Background: Insufficient or excessive gestational weight gain are associated with increased risks of adverse birth
and childhood outcomes. Increasing evidence suggests that exposure to bisphenols and phthalates may disrupt
hormonal pathways and thereby influence gestational weight gain.
Objective: To examine the associations of early and mid-pregnancy bisphenol and phthalate urine concentrations
with gestational weight gain.
Methods: In a population-based prospective cohort study among 1,213 pregnant women, we measured early and
mid-pregnancy bisphenol and phthalate urine concentrations. Maternal anthropometrics before pregnancy were
obtained by questionnaire and repeatedly measured at our research center during pregnancy. We used linear and
logistic regressions to evaluate the associations of bisphenols and phthalates with total and period-specific ge-
stational weight gain.
Results: Higher maternal total bisphenols and bisphenol S were associated with a lower total gestational weight
gain at nominal level. Stratification by body mass index group showed that higher total bisphenols and bisphenol
S were associated with lower total gestational weight gain specifically in normal weight women (respectively
−509 g [95% CI −819, −198] and −398 g [95% CI −627, −169]). Each log unit increase in early pregnancy
total bisphenol and bisphenol A urine concentrations were associated with lower mid- to late pregnancy ge-
stational weight gain in the whole group (effect estimates −218 g/log unit increase [95% CI −334, −102] and
−132 g/log unit increase [95% CI −231, −34], respectively). These associations were independent of mid-
pregnancy compounds. Mid-pregnancy bisphenols and phthalates concentrations were not associated with ge-
stational weight gain.
Discussion: Higher maternal bisphenol urine concentrations in early pregnancy may lead to reduced gestational
weight in second half of pregnancy. Further research is needed to assess the effects of maternal bisphenols and
phthalates urine concentrations on placental and fetal growth and development.
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1. Background
Insufficient or excessive gestational weight gain are associated with
increased risks of adverse birth and childhood outcomes. The US
Institute of Medicine and others have established criteria for excessive
as well as insufficient gestational weight gain, recognizing a substantial
literature documenting increases in adverse pregnancy, birth and off-
spring outcomes among women with excessive and insufficient gesta-
tional weight gain (Gaillard et al., 2013; Hrolfsdottir et al., 2015;
Kaimura et al., 2017; Marchi et al., 2015; Santos et al., 2019).
Gestational weight gain is a multifactorial phenotype. Risk factors
for excessive gestational weight gain include nulliparity, higher total
energy intake and smoking during pregnancy (Gaillard et al., 2013;
Nohr et al., 2008). Studies reporting associations of increased maternal
progesterone and leptin levels with greater gestational weight gain
suggest that hormonal responses may be important mechanisms con-
tributing to insufficient or excessive gestational weight gain (Lacroix
et al., 2016; Lof et al., 2009). A substantial literature has suggested that
synthetic chemicals, such as bisphenols and phthalates, can disrupt
hormones and thereby influence gestational weight gain (Buser et al.,
2014; Cantonwine et al., 2014; Harley et al., 2013; Philips et al., 2017;
Trasande et al., 2012; Valvi et al., 2015). For example, mono-ethyl
phthalate (MEP) has been associated with lower maternal progesterone
levels in the second trimester of pregnancy (Johns et al., 2015). Higher
maternal progesterone levels have been associated with increased ge-
stational weight gain (Lof et al., 2009). A study in mice reported in-
creased leptin concentrations in pregnant mice exposed to bisphenol A
(BPA) (Alonso-Magdalena et al., 2010). Exposure to bisphenols and
phthalates can be modified through behavioral modifications as well as
regulatory action (Carwile et al., 2009; Carwile et al., 2011; Harley
et al., 2016; Rudel et al., 2011). To our knowledge, the associations of
bisphenol and phthalate concentrations with maternal gestational
weight gain have not been studied yet.
We examined among 1,213 women participating in a population-
based prospective cohort study the associations of early and mid-
pregnancy bisphenol and phthalate urine concentrations with total and
period-specific gestational weight gain and the risks of insufficient or
excessive gestational weight gain.
2. Methods
2.1. Study design and population for analysis
The present study was embedded in the Generation R Study, a po-
pulation-based prospective cohort study from early pregnancy onwards
(Kooijman et al., 2016). In total, 8,879 women were enrolled in preg-
nancy, of which 76% before a gestational age of 18 weeks. The study
has been approved by the Medical Ethical Committee of the Erasmus
Medical Center in Rotterdam. Written consent was obtained from all
participating women (World Medical Association 2013). Bisphenol and
phthalate urine concentrations were measured in a subgroup study
among 1,406 mothers with an available early or mid-pregnancy urine
sample and whose children participated in postnatal studies. This
subgroup included singleton pregnancies only. We excluded women
without an available urine sample at both time points, without in-
formation on gestational weight gain until late pregnancy or total ge-
stational weight gain (n = 193), which led to 1,213 women included in
the analysis. For analysis on total gestational weight gain and clinical
gestational weight gain categories, we excluded women without in-
formation on total gestational weight gain (n = 397), leading to 823
women included in those analyses (Fig. 1).
2.2. Bisphenol and phthalate urine concentrations
As previously described, bisphenol and phthalate concentrations
were measured in a spot urine sample obtained from each subject
during the early and mid-pregnancy measurement (median gestational
age 13.1 weeks [inter-quartile range (IQR) 12.1–14.5 weeks] and
20.4 weeks [IQR 19.9–20.9], respectively). All urine samples were
collected between February 2004 and October 2005. Details on col-
lection, transportation and analysis methodology are provided else-
where (Philips et al., 2018).
We grouped urinary biomarkers for exposure to phthalates ac-
cording to their use in product categories. These product categories
were first personal care products , and second plasticizers to impart
flexibility to plastics. Based on these categories, phthalates we grouped
in low and high molecular weight phthalates. We calculated the
weighted molar sums for low molecular weight (LMW) phthalate, high
molecular weight (HMW) phthalate, di-2-ethylhexylphthalate (DEHP)
metabolites, and di-n-octylphthalate metabolites. Phthalic acid (PA)
was used separately as a proxy of total phthalate exposure. Among
HMW phthalates, DEHP is of particular interest because of its wide-
spread use in food packaging (Serrano et al., 2014). DNOP is also of
concern because, although banned from use in the European Union
since 2005, its primary metabolite, mono(3-carboxypropyl)phthalate
(mCPP), is still detectable in biosamples (Casas et al., 2011; Philips
et al., 2018). Individual compounds were included in if they were de-
tected in ≥20% of the samples. Also, bisphenols that were detected in
≥50% of the samples were analyzed separately. For bisphenol and
phthalate concentrations below the level of detection we substituted the
level of detection divided by the square root of 2, as routinely per-
formed in bisphenols and phthalates (Hornung and Reed 1990). Table 1
shows the metabolites that were included in all separate groups, their
values and detection rates.
2.3. Maternal anthropometrics
Maternal height (cm) and weight (kg) were measured at enrollment
without shoes and heavy clothing and body mass index (kg/m2) was
calculated. Weight was measured repeatedly during subsequent visits at
the research center (early pregnancy median gestational age 13.1 weeks
[IQR 12.1, 14.5], mid pregnancy median 20.4 weeks [IQR 19.9, 20.9],
and late pregnancy median 30.2 weeks [IQR 29.9, 30.8]). Information
on maternal weight just before pregnancy was obtained by ques-
tionnaire. In our population for analysis, 68.2% of all women were
enrolled before a gestational of 14 weeks. Information on total weight
during pregnancy was assessed by questionnaire 2 months after de-
livery (median gestational age at delivery 40.3 [IQR 39.3, 41.0]). Total
gestational weight gain was calculated as the difference between the
highest weight before birth and pre-pregnancy weight and was avail-
able in a subgroup of 823 mothers. For sensitivity analysis, gestational
weight gain until the late pregnancy visit was calculated as the differ-
ence between late pregnancy weight and pre-pregnancy weight and was
available for 1,209 mothers. Correlation of late pregnancy weight and
total weight was 0.96 (P-value < 0.001).
According to the IOM guidelines, we classified total gestational
weight gain as insufficient, sufficient and excessive in relation to ma-
ternal pre-pregnancy BMI (Institute of Medicine and National Research
Council Committee to Reexamine IOM Pregnancy Weight Guidelines
2009). Weight gain was further analyzed in specific periods of preg-
nancy (weight gain between the measured weight at the early and mid-
pregnancy visit; weight gain between the measured weight at the mid-
and late pregnancy visit; and weight gain between the measured weight
at the late pregnancy visit and reported total pregnancy weight).
2.4. Covariates
Covariates were selected based on previous analyses of potential
determinants of first trimester bisphenol and phthalate concentrations
(Philips et al., 2018). Information on maternal age at enrollment,
educational level, ethnicity, parity, pre-pregnancy weight, and folic
acid supplementation use was obtained from the first questionnaire at
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enrollment. Information on smoking and alcohol consumption was as-
sessed by questionnaires in each trimester (Jaddoe et al., 2010). Ma-
ternal daily dietary intake was assessed at enrollment using a modified
version of the validated semi-quantitative food-frequency questionnaire
(FFQ) of Klipstein-Grobusch et al. (Klipstein-Grobusch et al., 1998). The
FFQ covered the average dietary intake over the previous three months,
covering the dietary intake in the first trimester of pregnancy
(Tielemans et al., 2016). We used caloric intake derived from the FFQ
as a covariate in statistical analyses.
2.5. Statistical analysis
Differences in subject characteristics between groups of gestational
weight gain were assessed using one-way ANOVA tests for continuous
variables and chi-square tests for proportions. Non-response analysis
was performed to assess distributions of maternal characteristics and
investigated outcomes. For the main analyses, all bisphenol and
phthalate urinary metabolite concentrations were log-transformed to
account for right skewness in the distribution.
We performed multivariable linear and multinomial logistic re-
gressions to evaluate associations of early and mid-pregnancy urinary
concentrations with total gestational weight gain continuously, gesta-
tional weight gain per pregnancy period and clinical categories of ge-
stational weight gain. To investigate total gestational weight gain
continuously and in clinical categories, early and mid-pregnancy bi-
sphenol and phthalate groupings were used simultaneously to examine
the relative influence of early versus mid-pregnancy urinary con-
centrations. When testing associations of gestational weight gain in
specific pregnancy periods, metabolite concentrations of all earlier time
points were added simultaneously to the model to adjust for measures
at other visits. Therefore, models for early-to-mid-pregnancy gesta-
tional weight gain included metabolite concentrations in early preg-
nancy only. Because detection rates of bisphenol S (BPS) dropped below
50% in mid-pregnancy, early pregnancy BPS concentrations were ad-
justed for total bisphenol concentrations in mid-pregnancy.
For all significant models, subanalyses of individual bisphenol
compounds or phthalate metabolites were performed to determine
which metabolites were driving the association. Subanalysis of sig-
nificant models with early and mid-pregnancy concentrations of bi-
sphenols and phthalates used simultaneously were performed with the
separate compounds of the significant group together with the total
group of the other pregnancy period, to keep models comparable. As a
sensitivity analysis, we used multivariable linear regression models to
examine the associations between the logs of molar concentrations of
the metabolite groups with gestational weight gain until late preg-
nancy.
In all models, urinary concentrations of each bisphenol or phthalate
compound or grouping were converted to µg/g or µmol/g creatinine to
adjust for dilution (Barr et al., 2005). All models were adjusted for
maternal age, educational level, ethnicity, parity, daily dietary caloric
intake, folic acid supplement use, smoking, and alcohol consumption.
Higher pre-pregnancy BMI has been associated with a lower gestational
weight gain (Santos et al., 2018). Our previous studies showed that
higher pre-pregnancy BMI was associated with higher bisphenol and
phthalate concentrations in early pregnancy (Philips et al., 2018).
Therefore, models with gestational weight gain as outcome were ad-
ditionally adjusted for pre-pregnancy BMI. To investigate potential ef-
fect modification by pre-pregnancy BMI of the associations of bisphenol
and phthalate concentrations with gestational weight gain, we have
tested interaction terms with categories of pre-pregnancy BMI. Ad-
ditionally stratified analyses have been performed for significant in-
teractions. Non-linear effects of early and mid-pregnancy metabolite
concentrations on total gestational weight gain were assessed using
quartiles.
Missing data of the covariates were imputed using multiple im-
putation. Five imputed data sets were created. Effect estimates were
pooled to obtain the overall result, taking into account the within and
between imputation variance according to Rubin’s Rules (Rubin 1987).
The percentage of missing values within the population for analysis
were lower than or equal to 10%, except for maternal folic acid sup-
plementation use (17.0%) and daily dietary caloric intake (23.8%). To
correct for multiple hypothesis testing, each p-value was compared with
a threshold defined as 0.05 divided by the effective number of in-
dependent tests estimated based on the correlation between the
Fig. 1. Flowchart.
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exposures (p-value threshold of 0.011) (Li et al., 2012). All analyses
were performed using the Statistical Package of Social Sciences version
21.0 for Windows (SPSS Inc, Chicago, IL, USA).
3. Results
3.1. Subject characteristics
Mid-pregnancy urine concentrations of bisphenols and phthalates were
generally lower than in early pregnancy. Also, detection rates of BPS, bi-
sphenol F (BPF), mono-hexylphthalate (mHxP) and mono-2-heptylphtha-
late (mHpP) urine concentrations were considerably lower in mid-preg-
nancy (Table 1). Characteristics of the included mothers are given in
Table 2. Of all women, 19.1%, 30.0%, and 50.9% had insufficient, suffi-
cient, and excessive gestational weight gain, respectively. Women with
excessive gestational weight gain had a higher pre-pregnancy BMI and
were more often younger, smokers, and nulliparous. As shown in Sup-
plementary Table S1, nonresponse analysis showed similar distributions of
sociodemographic factors and other risk factors for gestational weight gain
in the subgroup study population as in the entire study cohort. However,
the subgroup of mothers with information on total gestational weight gain
tended to be slightly higher educated and healthier.
3.2. Bisphenol and phthalate urine concentrations and gestational weight
gain
Early and mid-pregnancy phthalates were not associated with total
gestational weight gain (Table 3). For total bisphenols and BPS, asso-
ciations with a decreased total gestational weight gain were observed at
nominal level.
We observed effect modification by pre-pregnancy BMI of the as-
sociations of bisphenol and phthalate concentrations with total gesta-
tional weight gain (statistical interaction p-value < 0.1) for early
pregnancy total bisphenols, BPA, BPS, PA, LMW phthalate metabolites
and DEHP metabolites (data not shown). Further stratification yielded
significant results for total bisphenols and BPS in the normal weight
group with a decreased total gestational weight gain (respectively
−509 g (95% CI −819, −198) and −398 g (95% CI −627, −169),
both p-value = 0.001). To illustrate, an interquartile range increase in
total bisphenols was associated with −864 g (95% CI −1391, −336)
decrease in total gestational weight gain among normal weight women.
Because the numbers per stratum were low for underweight and obese
women these analyses were not presented as main analyses. Assessment
of potential non-linear association of early and mid-pregnancy bi-
sphenol and phthalate concentrations using quartiles did not reveal any
Table 2
Subject characteristics by gestational weight gain classification1.
Total Insufficient gestational weight
gain
Sufficient gestational weight
gain
Excessive gestational weight
gain
p-value2
n = 1,213 n = 157 n = 247 n = 419
Maternal age (years) 30.6 (4.8) 31.2 (4.5) 31.8 (4.1) 30.6 (4.6) 0.005
Pre-pregnancy BMI (kg/m2)* 22.7 (20.8, 25.3) 22.1 (20.7, 23.9) 21.9 (20.2, 23.7) 23.2 (21.0, 25.7) 0.000
Educational level 0.020
Low 583 (48.1) 70 (45.2) 85 (34.7) 187 (45.3)
High 596 (49.1) 85 (54.8) 160 (65.3) 226 (54.7)
Missings 35 (2.8) – – –
Ethnicity 0.751
Dutch/European 756 (62.3) 107 (69.0) 176 (71.3) 302 (72.2)
Non-European 452 (37.3) 48 (31.0) 71 (28.7) 116 (27.8)
Missings 5 (0.4) – – –
Parity 0.001
Nulliparous 742 (61.2) 85 (54.1) 152 (61.5) 293 (69.9)
Multiparous 471 (38.8) 72 (45.9) 95 (38.5) 126 (30.1)
Missings – – – –
Daily dietary caloric intake (kcal) 2080 (5 0 8) 2035 (5 4 8) 2145 (4 9 0) 2113 (4 8 5) 0.163
Creatinine early pregnancy (< 18 weeks) (μg/mL)* 1030 (491, 1661) 958 (522, 1582) 1026 (450, 1705) 1032 (472, 1642) 0.647
Creatinine mid-pregnancy (18–25 weeks) (μg/mL)* 1164 (740, 1818) 1291 (814, 2025) 1222 (676, 1861) 1106 (709, 1654) 0.375
Smoking 0.000
Never 867 (71.5) 136 (86.6) 192 (77.7) 286 (68.3)
Until pregnancy was known 108 (8.9) 7 (4.5) 19 (7.7) 50 (11.9)
Continued 160 (13.2) 7 (4.5) 21 (8.5) 57 (13.6)
Missings 78 (6.4) 7 (4.5) 15 (6.1) 26 (6.2)
Alcohol consumption 0.566
Never 491 (40.5) 64 (40.8) 84 (34.0) 157 (37.5)
Until pregnancy was known 193 (15.9) 24 (15.3) 47 (19.0) 62 (14.8)
Continued 451 (37.2) 63 (40.1) 101 (40.9) 172 (41.1)
Missings 78 (6.4) 6 (3.8) 15 (6.1) 28 (6.7)
Folic acid supplementation 0.893
No 191 (15.7) 18 (11.5) 28 (11.3) 51 (12.2)
Start first 10 weeks 330 (27.2) 40 (25.5) 62 (25.1) 122 (29.1)
Start periconceptional 484 (39.9) 72 (45.9) 116 (47.0) 189 (45.1)
Missings 208 (17.1) 27 (17.2) 41 (16.6) 57 (13.6)
Early to-mid pregnancy weight gain (kg)* 3.0 (2.0, 5.0) – – –
Mid- to late pregnancy weight gain (kg)* 5.0 (3.5, 7.0) – – –
Late to total pregnancy weight gain (kg)* 4.5 (3.0, 7.0) – – –
Total gestational weight gain(kg)* 15.0 (12.0, 18.0) – – –
Gestational weight gain until late pregnancy (kg)* 10.0 (8.0, 13.0) – – –
1 Values are means (standard deviation) or numbers of subjects (percentage). Only women with available information on total gestational weight gain were
classified in a total gestational weight gain category (n = 823).
2 Differences between groups of insufficient, sufficient and excessive gestational weight gain were assessed using one-way ANOVA tests for continuous variables
and chi-square tests for proportions.
* Median (IQR range)
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indications of non-linearity (data not shown).
Each log unit increase in early pregnancy total bisphenol urine
concentrations was associated with −218 g (95% CI −334, −102)
gestational weight gain in mid- to late pregnancy. Analysis of individual
bisphenol compounds in early pregnancy showed that maternal BPA
concentrations were driving this association with a −132 g (95% CI
−231, −34) lower mid- to late pregnancy weight gain/log unit in-
crease. The associations of early pregnancy BPS and BPF urine con-
centrations with gestational weight gain in mid-to-late pregnancy
tended toward nominal significance (Table 3 and Supplementary Table
S2). Early pregnancy DNOP metabolite concentrations were associated
with mid- to late pregnancy weight gain at nominal level. Bisphenol and
phthalate concentrations in early and mid-pregnancy were not asso-
ciated with early-to-mid-pregnancy weight gain or late pregnancy-to-
total gestational weight gain. We did not observe effect modification by
pre-pregnancy BMI for the analyses on gestational weight gain during
specific periods of pregnancy (data not shown).
3.3. Bisphenol and phthalate levels and clinical categories of gestational
weight gain
Table 4 shows that bisphenol and phthalate urine concentrations in
early and mid-pregnancy were not associated with insufficient or ex-
cessive gestational weight gain. Early pregnancy LMW phthalate me-
tabolites were associated with higher odds of insufficient gestational
weight gain, However, this associations attenuated into non-sig-
nificance correction for multiple testing.
3.4. Sensitivity analysis
Sensitivity analysis shows that the associations of early pregnancy
bisphenols with gestational weight gain until late pregnancy somewhat
attenuated but had the same directionality (Supplementary Table S3).
Early pregnancy BPS concentrations were associated with gestational
weight gain until late pregnancy at nominal level, adjusted for total
bisphenol concentrations in mid-pregnancy. However, this associations
attenuated into non-significance after correction for multiple testing.
4. Discussion
Results from this prospective population-based cohort study showed
that among normal weight women total gestational weight gain was
lower for women with higher total bisphenols or BPS concentrations in
early pregnancy, independent of bisphenol concentrations in mid-
pregnancy. Early pregnancy total bisphenols and BPA were associated
with a lower gestational weight gain in mid- to late pregnancy in the
whole group.
4.1. Interpretation of main findings
To the best of our knowledge, this is the first prospective study that
examined the associations of maternal bisphenols and phthalates con-
centrations with gestational weight gain. Our findings suggest that ma-
ternal bisphenol concentrations in early pregnancy are associated with a
lower gestational weight gain, mainly in second half of pregnancy.
Additionally, the findings suggest that women with a normal weight are
most vulnerable for effects of early pregnancy bisphenols on gestational
weight gain. We did not observe associations of bisphenol and phthalate
concentrations with clinical categories of gestational weight gain. An
additional analysis suggests that among women with insufficient weight
gain each log unit increase in total bisphenols was associated with a
stronger reduction in weight gain than in women with sufficient and
excessive weight gain (data not shown). Since we have only used early
and mid-pregnancy bisphenol and phthalate urine concentrations, we
cannot rule out that also late pregnancy bisphenol and phthalate con-
centrations have a certain effect on gestational weight gain. However,
this seems unlikely, since the associations of early pregnancy exposures
were independent of mid pregnancy exposure concentrations.
Previous cross-sectional studies investigating determinants of bi-
sphenols and phthalates reported associations of higher concentrations
Table 3
Associations of early and mid-pregnancy bisphenol and phthalate urine concentrations with gestational weight gain (n = 1,213).
Gestational weight gain (grams)
Early to mid-pregnancy, (95%
Confidence Interval) (n = 1,205)
Mid- to late pregnancy, (95%
Confidence Interval) (n = 1,207)1
Late pregnancy to total, (95%
Confidence Interval) (n = 819)1
Total (95% Confidence
Interval) (n = 823)1
Early pregnancy (< 18 weeks)
Total bisphenols 0 (−98, 98) −218 (−334, −102) * † −82 (−261, 98) −354 (−641, −68)*
Bisphenol A 17 (−66, 100) −132 (−231, −34)* † −54 (−205, 98) −125 (−367, 117)
Bisphenol S2 −26 (−97, 44) −76 (−160, 7) −41 (−169, 87) −261 (−466, −56)*
Phthalic acid 32 (−84, 147) −139 (−277, 0) −131 (−334, 71) −50 (−375, 274)
LMW phthalate metabolites 63 (−33, 159) −110 (−230, 9) −196 (−375, −17)* −191 (−478, 96)
HMW phthalate metabolites 13 (−113, 140) −133 (−285, 18) −175 (−411, 61) −268 (−646, 111)
DEHP metabolites 24 (−100, 147) −122 (−270, 27) −183 (−413, 47) −259 (−627, 109)
DNOP metabolites 40 (−83, 162) −176 (−324, −29)* −218 (−436, −1)* −319 (−666, 29)
Mid-pregnancy (18–25 weeks)
Total bisphenols – −119 (−251, 14) 161 (−35, 356) 143 (−168, 453)
Bisphenol A – −112 (−238, 14) 151 (−36, 338) 147 (−150, 444)
Bisphenol S – – – –
Phthalic acid – −125 (−271, 21) 217 (−6, 440) 33 (−323, 389)
LMW phthalate metabolites – −86 (−221, 49) 145 (−56, 346) 60 (−262, 381)
HMW phthalate metabolites – −149 (−304, 5) 112 (−129, 353) −30 (−415, 354)
DEHP metabolites – −140 (−292, 11) 156 (−81, 393) 64 (−315, 444)
DNOP metabolites – −68 (−235, 99) 96 (−149, 342) −112 (−505, 280)
Estimates are based on multivariate regression analyses. Increases are per log unit increase in early and mid-pregnancy urinary Total bisphenols/BPA/BPS/Phthalic
acid/LMW/HMW/DEHP/DNOP metabolite concentrations per gram creatinine. All models are adjusted for maternal age, maternal pre-pregnancy BMI, daily dietary
caloric intake, parity, ethnicity, education, maternal smoking, maternal alcohol, and folic acid supplementation. In total, 1,213 women are included in the analyses in
this table. Due to random nonresponse, not all women had available information about all the weights.
1 Early and mid-pregnancy compounds have been used in the model simultaneously, yielding estimates adjusted for compounds at the other time point.
2 For models of early pregnancy BPS, the total group of mid-pregnancy bisphenols has been used in the model simultaneously, if applicable. Estimates for mid-
pregnancy total bisphenols in these models are not presented.
* p-value < 0.05
† significant after multiple testing correction
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of BPA and phthalates in pregnant women with a higher BMI (Arbuckle
et al., 2014; Cantonwine et al., 2014; Lewin et al., 2017; Philips et al.,
2018; Valvi et al., 2015). A recent prospective study of pregnant women
reported a negative association between DEHP metabolites in early
pregnancy and early gestational weight gain (Bellavia et al., 2017).
Persistent organic pollutants (POPs) have also been examined for as-
sociations with gestational weight gain. Similar to bisphenols and
phthalates, the majority of POPs are lipophilic chemicals, except for
perfluoroalkyl substances (PFASs) (DeWitt 2015; Stockholm
Convention). The results from studies investigating effects of POPs on
gestational weight gain show different associations with gestational
weight gain for the PFASs and other POPs. Higher per-
fluorooctanesulfonate (PFOS) levels – a perfluoroalkyl substance - be-
fore and in early pregnancy have been associated with a higher gesta-
tional weight gain in normal and underweight women, while in
overweight women this effect was not observed (Ashley-Martin et al.,
2016; Jaacks et al., 2016). Other POPs, including dichlorodiphenyl
dichloroethene (DDE), polychlorinated bisphenyls (PCBs) in early
pregnancy and neonatal DDE, hexachlorocyclohexanes (HCHs), PCBs
and polybrominated diphenyl ethers (PBDEs), have been associated
with lower or even insufficient gestational weight gain (Herbstman
et al., 2007; Vafeiadi et al., 2014; Vizcaino et al., 2014). Thus our study
results add to previous studies suggesting that various environmental
exposures in specifically early pregnancy may influence gestational
weight gain.
Gestational weight gain is a complex phenotype (Gaillard et al.,
2013; Nohr et al., 2008). Besides increased maternal fat storage, several
compartments could be responsible for the observed change in gesta-
tional weight gain. Information about maternal fat storage, measure-
ments of body composition during pregnancy would be informative.
However, measurements of body composition during pregnancy were
not available in the current study. In our previous study, we did not
observe associations of early pregnancy bisphenol and phthalate con-
centrations with placental weight at birth (Philips et al., 2019). A
previous study within the same cohort suggested lower fetal growth in
association with maternal BPA concentrations (Snijder et al., 2013).
Gestational weight gain, in particular in mid- and late pregnancy, is
associated with birth weight (Ay et al., 2009; Gaillard et al. 2013). In a
recent rodent study, early pregnancy BPA exposure was associated with
impaired remodeling of the uterine spiral arteries and intrauterine
growth restriction (Muller et al., 2018). Altogether, previous studies
and our results suggest that higher maternal bisphenol urine con-
centrations in early pregnancy may lead to reduced gestational weight
in second half of pregnancy. Further research is needed to assess the
effects of maternal bisphenol and phthalate urine concentrations on
different aspects of gestational weight gain, such as placental and fetal
growth and development.
4.2. Strengths and limitations
Strengths of this study were the prospective data collection from
early pregnancy onwards, large sample size of 1,213 participants with a
urine sample in early and mid-pregnancy, and information on gesta-
tional weight gain. The subgroup of women with information on total
gestational weight gain tended to a slightly higher educated, healthier
population, which might have influenced results. However, sensitivity
analysis of gestational weight gain until late pregnancy and period-
specific gestational weight gain argue against biased estimates. The
response rate at baseline was 61% (Kooijman et al., 2016). Although we
cannot rule out selection towards a relatively healthy population, se-
lection bias in cohort studies is more likely to arise from loss to follow
up rather than from non-response at baseline (Nohr et al., 2006). Ad-
ditionally, models have been adjusted for several potential proxies for
health, reducing the odds of biased estimates due to selection bias. Less
variation in our study population than in the general population may
have led to underestimation of effect estimates. Repeated exposures
were analyzed using multiple regression analysis, enabling investiga-
tion of potential windows of vulnerability (Chen et al., 2015). In our
analysis, collinearity was not an issue (Supplementary Table S4). Bi-
sphenol and phthalate metabolites were measured in spot urine samples
in early and mid-pregnancy and typically have half-lives of less than
24 h (Braun et al., 2013; Mattison et al., 2014). A single spot urine
sample for phthalates could reasonably reflect exposure for up to three
months (Hauser et al. 2004), but bisphenols have a high temporal
variability, even over the day (Vernet et al., 2019). This non-differential
misclassification is expected to lead to attenuation bias in dose-response
relationships.
A common method to account for dilution of urinary chemical
concentrations is via creatinine adjustment (O'Brien et al., 2016). En-
dogenous creatinine clearance, measured by 24-hr urine collection,
remains the most precise estimation of the glomerular filtration rate in
pregnant women (Ahmed et al., 2009). A recent study suggested that
specific gravity adjustment is a better correction method in pregnant
women (MacPherson et al., 2018). Unfortunately, specific gravity
measurements were not available. Additional analysis of models
without creatinine adjustment yielded similar results (data not shown).
Maternal weight was measured during the visits at our research
center. Information on maternal pre-pregnancy weight and total weight
during pregnancy was self-reported. Self-reported weight tends to be
underestimated, leading to misclassification. Consequently, this might
have led to biased estimates. In the period-specific analysis, early-to-
Table 4
Associations of early and mid-pregnancy bisphenol and phthalate urine con-
centrations with clinical categories of gestational weight gain (n = 823).
Insufficient weight
gain, Odds Ratio
(95% Confidence
Interval)
(n = 157)
Excessive weight gain,
Odds Ratio (95%
Confidence Interval)
(n = 419)
Early pregnancy
(< 18 weeks)
Total bisphenols 0.96 (0.82, 1.13) 0.91 (0.80, 1.03)
Bisphenol A 0.97 (0.84, 1.11) 0.96 (0.86, 1.07)
Bisphenol S1 1.03 (0.92, 1.15) 0.96 (0.88, 1.06)
Phthalic acid 1.18 (0.98, 1.41) 1.11 (0.96, 1.28)
LMW phthalate metabolites 1.18 (1.01, 1.39)* 1.03 (0.91, 1.17)
HMW phthalate
metabolites
1.16 (0.94, 1.43) 1.00 (0.84, 1.18)
DEHP metabolites 1.16 (0.94, 1.42) 1.00 (0.85, 1.18)
DNOP metabolites 1.15 (0.95, 1.40) 0.97 (0.83, 1.13)
Mid pregnancy
(18–25 weeks)
Total bisphenols 0.94 (0.79, 1.12) 1.02 (0.89, 1.17)
Bisphenol A 0.94 (0.79, 1.11) 1.03 (0.90, 1.17)
Bisphenol S – –
Phthalic acid 0.97 (0.80, 1.19) 1.00 (0.86, 1.17)
LMW phthalate metabolites 0.97 (0.81, 1.16) 0.97 (0.84, 1.12)
HMW phthalate
metabolites
0.92 (0.75, 1.14) 0.97 (0.82, 1.14)
DEHP metabolites 0.91 (0.74, 1.12) 0.98 (0.83, 1.15)
DNOP metabolites 0.96 (0.78, 1.19) 0.88 (0.74, 1.04)
Estimates are based on multivariate regression analyses. Reference category is
sufficient weight gain. Only women with available information on total gesta-
tional weight gain were classified in a total gestational weight gain category.
Increases are per log unit increase in early and mid-pregnancy urinary total bi-
sphenols/BPA/BPS/Phthalic acid/LMW/HMW/DEHP/DNOP metabolite con-
centrations per gram creatinine. Models are adjusted for maternal age, daily dietary
caloric intake, parity, ethnicity, education, maternal smoking, maternal alcohol,
and folic acid supplementation. Early and mid-pregnancy compounds have been
used in the model simultaneously, yielding estimates adjusted for compounds at the
other time point. 1For models of early pregnancy BPS, the total group of mid-
pregnancy bisphenols has been used in the model simultaneously, if applicable.
Estimates for second trimester total bisphenols in these models are not presented.
* p-value < 0.05
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mid and mid-to-late pregnancy analyses were based on measured
weights only and provide therefore the most reliable estimates. Detailed
information on a large number of potential confounding factors was
available. Nonetheless, due to the observational design of the study,
residual confounding due to unmeasured environmental exposures,
socio-demographic or lifestyle factors still might still be an issue.
4.3. Conclusion
Higher maternal bisphenol urine concentrations in early pregnancy
may lead to reduced gestational weight in second half of pregnancy.
Further research is needed to assess the effects of maternal bisphenols
urine concentrations on placental and fetal growth and development.
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